Newspaper publication of Unaudited Financial Results for Quarter and year to date ended 31.12.2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech has submitted to BSE copies of newspaper advertisements containing its unaudited financial results for the quarter ended 31 December 2025 (Q3 FY26) and the nine months ended on that date. The ads were published in Business Standard (both English and Hindi editions) on 16 February 2026, as required under SEBI LODR Regulation 47. The published results detail total income, net profit before and after tax, total comprehensive income, equity share capital, and EPS (basic and diluted) on standalone and consolidated bases, with prior-period comparisons. The audit committee reviewed the results and the board approved them on 14 February 2026.
This is a routine compliance filing confirming that Q3 FY26 results have been publicly disclosed via newspaper publication as mandated by SEBI. No new material information is being communicated beyond what was already disclosed in the earlier Regulation 33 results filing.